
Composition
Gliclazide 30mg + Metformin Hydrochloride 500mg (Extended Release)
GDZIDE MXR 30 is an extended-release antidiabetic tablet combining Gliclazide (sulfonylurea) and Metformin for sustained blood sugar management throughout the day in type 2 diabetes.
Packing
10x15 Tablets
Storage
Cool & dry place
Form
tablet
Quality
FSSAI / GMP
Rx — Prescription Drug. This product should be used only under the supervision and prescription of a registered medical practitioner. Self-medication is not recommended.
* Not everyone experiences these side effects. Consult your doctor if symptoms persist.
Storage Instructions
Store in a cool, dry and dark place. Protect from light and moisture.
Packing
10x15 Tablets
Marketed By
Tawshi Healthcare Pvt. Ltd.
SR. No. 95, Mahadev Nagar, Manjari BK, Hadapsar, Pune – 412307
FSSAI License
11524079000326

Levosalbutamol + Ambroxol + Guaiphenesin

Ambroxol Hydrochloride + Levosalbutamol Sulphate + Guaiphenesin Syrup

Ambroxol Hydrochloride + Guaiphenesin + Terbutaline Sulphate + Menthol

Phenylephrine HCl + Chlorpheniramine Maleate Syrup I.P.